Key Points
• A powerful House committee has approved a spending bill and report expressing concerns over health risks from cannabis-derived products making unlawful claims.
• The committee is urging federal action against manufacturers of these products, highlighting a "proliferation" of potentially misleading items.
• Separately, the report encourages further research into the therapeutic benefits of psychedelics.
What This Means for DC
What this means for DC: While DC's cannabis market operates under unique gifting and medical regulations, federal scrutiny on health claims could influence product labeling and marketing standards. Local businesses and consumers should be aware of potential shifts in federal enforcement that might trickle down and impact the types of products and claims seen in the District.
Original Source: Marijuana Moment
Original headline: "Congressional Committee Wants Feds To Go After Cannabis Product Manufacturers Making Unlawful Health Claims"
Read original article at Marijuana Moment